Advertisement

Vitreous Substitutes and Vitreous Surgery

  • C. L. Schepens

Abstract

For many years ophthalmologists thought that the vitreous should not be disturbed surgically. In the process of learning to deal with more complex cases of retinal detachment, instruments and techniques were devised to operate successfully on pathological vitreous that clearly interfered with retinal reattachment. The procedures consist in the injection of vitreous substitutes and the use of vitreous surgery.

Keywords

Hyaluronic Acid Retinal Detachment Vitreous Cavity Scleral Buckling Proliferative Vitreoretinopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    DEUTSCHMANN, R. — Über ein neues Heilverfahren bei Netzhautablösung. Beitr. Augenheilkd., 1895, 20, 1–80.Google Scholar
  2. (2).
    CONSTABLE, I.J., SWANN, D.A. — Vitreous substitution with gases. Arch. Ophthalmol., 1975, 93, 416–419.PubMedCrossRefGoogle Scholar
  3. (3).
    VAN HORN, D.L., EDELHAUSER, H.F., AABERG, T.M., PEDERSON, H. J. — In vivo effects of air and sulfur hexafluoride gas on rabbit corneal endothelium. Invest. Ophthalmol., 1972, 11, 1028–1036.Google Scholar
  4. (4).
    CONSTABLE, I. J. — Effects of vitreous replacement with gases • preliminary note on perfluoropentane. In: Freeman H.M., Hirose T., Schepens C.L. (eds.), Vitreous surgery and advances in fundus diagnosis and treatment. New York: Appleton-Century-Crofts, 1977, 427–431.Google Scholar
  5. (5).
    NORTON, E. W. D. — Intraocular gas in the management of selected retinal detachments. Trans. Am. Acad. Ophthalmol. Otolaryngol.,1973, 77, OP85–98.Google Scholar
  6. (6).
    FINEBERG, E., MACHEMER, R., SULLIVAN, P., NORTON, E. W. D., HAMASAKI, D., ANDERSON, D. — Sulfur hexafluoride in owl monkey vitreous cavity. Am. J. Ophthalmol., 1975, 79, 67–76.PubMedGoogle Scholar
  7. (7).
    STINSON, T. W., DONLON, J. V. — Interaction of intraocular SF6 and air with nitrous oxide. Anesthesiology,1979, 51 (suppl.) S: 61 (abstr.).Google Scholar
  8. (8).
    PETERS, M.A., ABRAMS, G.W., HAMILTON, L.H., BURKE, J.M., SCHRIEBER, T. M. — The nonexpansile, equilibrated concentration of perfluoropropane gas in the eye. Am. J. Ophthalmol., 1985, 100, 831–839.PubMedGoogle Scholar
  9. (9).
    LINCOFF, H., KREISSIG, I. — Application of xenon gas to clinical retinal detachment. Arch. Ophthalmol., 1982, 100, 1083–1085.PubMedCrossRefGoogle Scholar
  10. (10).
    LINCOFF, A., KREISSIG, I. — Intravitreal behavior of perfluorocarbons. Dey. Ophthalmol., 1981, 2, 17–23.Google Scholar
  11. (11).
    CHANG, S., COLEMAN, J., LINCOFF, H., WILCOX, L.M., BRAUNSTEIN, R.A., MAISEL, J. M. — Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am. J. Ophthalmol., 1984, 98, 180–188.PubMedGoogle Scholar
  12. (12).
    LINCOFF, H., COLEMAN, J., KREISSIG, I., RICHARD, G., CHANG, S., WILCOX, L. M. — The perfluorocarbon gases in the treatment of retinal detachment. Ophthalmology, 1983, 90, 546–551.PubMedGoogle Scholar
  13. (13).
    CHANG, S., LINCOFF, H.A., COLEMAN, J., FUCHS, W., FARBER, M. E. — Per-fluorocarbon gases in vitreous surgery. Ophthalmology, 1985, 92, 651–656.Google Scholar
  14. (14).
    LINCOFF, A., LINCOFF, H., IWAMOTO, T., JACOBIEC, F., KREISSIG, I. — Perfluoro-n-butane: a gas for a maximum duration retinal tamponade. Arch. Ophthalmol., 1983, 101, 460–462.PubMedCrossRefGoogle Scholar
  15. (15).
    MESTER, U., KROLL, P., VOELKER, B., KREISSIG, I. — Intraocular SF6 gas application: treatment of retinal detachments caused by holes at the posterior pole. Ophthalmologica, 1983, 186, 151–155.PubMedCrossRefGoogle Scholar
  16. (16).
    LINCOFF, H. — A small bubble technique for manipulating giant retinal tears. Ann. Ophthalmol., 1981, 13, 241–243.Google Scholar
  17. (17).
    KREISSIG, I., STANOWSKY, A., LINCOFF, H., RICHARD, H. — The treatment of difficult retinal detachments with an expanding gas bubble without vitrectomy. Graefe’s Arch. Clin. Exp. Ophthalmol., 1986, 224, 51–54.PubMedCrossRefGoogle Scholar
  18. (18).
    HAUT, J. — L’intervention vitrectomie-silicone. A propos de 1000 cas. Paris: Masson, 1984.Google Scholar
  19. (19).
    NI, C., WANG, W.J., ALBERT, D. M., SCHEPENS, C. L. — Intravitreous silicone injection: histopathologic findings in a human eye after 12 years. Arch. Ophthalmol., 1983, 101, 1399–1401.PubMedCrossRefGoogle Scholar
  20. (20).
    KIRCHHOF, B., TAVAKOLIAN, U., PAULMANN, H., HEIMANN, K. — Histopathological findings in eyes after silicone oil injection. Graefe’s Arch. Clin. Exp. Ophthalmol., 1986, 224, 34–37.PubMedCrossRefGoogle Scholar
  21. (21).
    CIBIS, P.A., BECKER, B., OKUN, E., CANAAN, S. — The use of liquid silicone in retinal detachment surgery. Arch. Ophthalmol., 1962, 68, 509–519.CrossRefGoogle Scholar
  22. (22).
    WATZKE, R. C. — Silicone retinopiesis for retinal detachment: a long-term clinical evaluation. Arch. Ophthalmol., 1967, 77, 185–196.PubMedCrossRefGoogle Scholar
  23. (23).
    DUFOUR, R. — Experience with intraocular silicone injection. In: McPherson A. (ed.), New and controversial aspects of retinal detachment, New York: Heober Med. Div., Harper and Row, 1968, 377–382.Google Scholar
  24. (24).
    Okun, E. — Therapy of retinal detachment complicated by massive preretinal fibrosis. In: Symposium on retina and retinal surgery St. Louis: C.V. Mosby, 1969, 278293.Google Scholar
  25. (25).
    FELTESSE-KOEGLER,M.C — Etude de 300 cas de décollement de rétine opérés par la technique vitrectromie-tamponnement interne par l’huile de silicone. 1983, Thèse Médecine, Paris, XIII.Google Scholar
  26. (26).
    LEAN, J. S., LEAVER, P.K., COOLING, R.J., MCLEOD, D.–Management of complex retinal detachment by vitrectomy and fluid silicone exchange. Trans. Ophthalmol. Soc. UK, 1982, 102, 203–205.PubMedGoogle Scholar
  27. (27).
    SCOTT, J. D. — Use of liquid silicone in vitrectomized eyes. Dey. Ophthalmol., 1981, 2, 185–190.Google Scholar
  28. (28).
    ZIVOJNOVIC, R., MERTENS, D. A. E., PEPERKAMP, E. — Das flüssige Silikon in der Amotiochirurgie. Bericht über 280 Fälle. Weitere Entwicklung der Technik. Klin. Monatsbl. Augenheilkd., 1982, 181, 444–452.PubMedCrossRefGoogle Scholar
  29. (29).
    MCCUEN, B. W., LANDERS, M. B., MACHEMER, R. — The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy. Graefe’s Arch. Clin. Exp. Ophthalmol., 1986, 224, 38–39.PubMedCrossRefGoogle Scholar
  30. (30).
    SCHEPENS, C.L. — Vitreous injection of viscous substances. In: Neetens A. (ed.), Modern concepts in vitreo-retinal diseases, Antwerp: University of Antwerp UTA Press, 1985, 151–158.Google Scholar
  31. (31).
    GONVERS, M. — Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy. Am. J. Ophthalmol., 1985, 100, 239–245.Google Scholar
  32. (32).
    CHAUVAUD, D., Barthelémy, F., FROTA, A.–Utilisation de l’huile de silicone en tamponnement transitoire dans le traitement des décollements de rétine avec rétraction vitréo-rétinienne. J. Fr. Ophtalmol., 1984, 7, 279–284.PubMedGoogle Scholar
  33. (33).
    KAREL, I., FILIPEC, M., OBENBERGER, J.–Specular microscopy of the corneal endothelium after liquid silicone injection into the vitreous in complicated retinal detachments. Graefe’s Arch. Clin. Exp. Ophthalmol., 1986, 224, 195–200.Google Scholar
  34. (34).
    COCKERHAM, W., SCHEPENS, C.L., FREEMAN, H. M.–Silicone injection in retinal detachment. Mod Probl. Ophthalmol., 1969, 8, 525–540.Google Scholar
  35. (35).
    LEE, P. F., DONOVAN, R. H., MUKAI, N., SCHEPENS, C.L., FREEMAN, H.M. - Intravitreous injection of silicone: an experimental study. I. Clinical picture and histology of the eye. Ann. Ophthalmol.,1969, 1(2),15–25.Google Scholar
  36. (36).
    MUKAI, N., LEE P. F., SCHEPENS, C. L.–Intravitreous injection of silicone: an experimental study. II. Histochemistry and electron microscopy. Ann. Ophthalmol., 1972, 4, 273–287.PubMedGoogle Scholar
  37. (37).
    LEAVER, P.K., GREY, R.H.B., GARNER, A.–Complications following silicone oil injections. Mod. Probi. Ophthalmol., 1979, 20, 290–294.Google Scholar
  38. (38).
    RENTSCH, F.J., ATZLER, P., LEISENHOFF, H.–Histologische und electron mikroskopische Untersuchungen an einem menschlichen Auge nach mehrjahriger intravitrealer Silikonimplantation. Ber. Zusammenkunft Dtsch. Ophthalmol. Ges., 1978, 75, 70–74.PubMedGoogle Scholar
  39. (39).
    CHAUVAUD, D., FRAISSE, F., Verdière, B.–A propos d’un cas d’oedème aigu du poumna observé après injection intra-oculaire de silicone. J. Fr. Ophtalmol., 1983, 6, 635–637.PubMedGoogle Scholar
  40. (40).
    BARTHélemy, F., CHAUVAUD, D., FROTA, A.–Utilisation de l’huile de silicone en tamponnement transitoire dans le traitement des décollements de rétine avec rétraction vitréo-rétinienne. J. Fr. Ophtalmol., 1984, 7, 273–277.PubMedGoogle Scholar
  41. (41).
    MIYAMOTO, K., REFOJO, M.F., TOLENTINO, F.I., FOURNIER, G.A., ALBERT, D. M.–Perfluoroether liquid as a long-term vitreous substitute: an experimental study. Retina, 1984, 4, 264–268.PubMedCrossRefGoogle Scholar
  42. (42).
    MIYAMOTO, K., REFOJO, M.F., TOLENTINO, F.I., FOURNIER, G.A., ALBERT, D.M.–Fluorinated oils as experimental vitreous substitutes. Arch. Ophthalmol., 1986, 104, 1053–1056.PubMedCrossRefGoogle Scholar
  43. (43).
    CHAN, I.M., TOLENTINO, F.I., REFOJO, M.F., FOURNIER, G., ALBERT, D.M.–Vitreous substitute: experimental studies and review. Retina, 1984, 4, 51–59.PubMedCrossRefGoogle Scholar
  44. (44).
    HOGEN-ESCH, T.E., SHAH, K. R., FITZGERALD, C. R.–Development of injectable poly(glyceryl methacrylate) hydrogels for vitreous prosthesis. J. Biomed. Mater. Res., 1976, 10, 975–976.PubMedCrossRefGoogle Scholar
  45. (45).
    FECHNER, P.U., FECHNER, M.U.–Methylcellulose and lens implantation. Br. J. Ophthalmol., 1983, 67, 259–263.PubMedCrossRefGoogle Scholar
  46. (46).
    FECHNER, P. U.–Preparation of 2% hydroxypropyl methylcellulose for vitreous surgery. Am. Intraocular Implant. Soc. J., 1985, 11, 606–607.Google Scholar
  47. (47).
    ARON-ROSA, D., COHN, H.C., ARON, J.J., BOUQUETY, C.–Methylcellulose instead of Healon in extracapsular surgery with intraocular lens implantation. Ophthalmology, 1983, 90, 1235–1238.PubMedGoogle Scholar
  48. (48).
    WILHELMUS, K.R., MOURA, R. A.–Pseudovitreous fluid based on sodium carboxymethylcellulose. Ann. Ophthalmol., 1984, 16, 350–352.PubMedGoogle Scholar
  49. (49).
    SCHEPENS, C.L.–Retinal detachment and allied diseases. Philadelphia: W.B. Saunders, 1983. (a) vol. 2, 747–769; (b) voL 2, 891–944; (c) vol. 2, 770–804; (d) vol. 2, 797–801; (e) vol. 2, 864–865; (f) vol. 2, 893–896; (g) vol. 2, 897–908.Google Scholar
  50. (50).
    BALAZS, E.A. - The vitreous. Int. Ophthalmol. Clin,1973, 13(3),169–187.Google Scholar
  51. (51).
    BALAZS, E. A., HULTSCH, E.–Replacement of the vitreous with hyaluronic acid, collagen and other polymers. In: Irvine, A. R., O’Malley C. (eds.), Advances in vitreous surgery, Springfield, Ill.: Charles C. Thomas, 1976, 601–623.Google Scholar
  52. (52).
    HULTSCH, E., BALAZS, E.A. - Pharmacological studies on the effect of intravitreal implantation of Na-hyaluronate. Invest. Ophthalmol. Vis. Sci.,1974, 13 (ARVO suppl.), 42 (abstr.).Google Scholar
  53. (53).
    HULTSCH, E. - Pathobiology of vitreous replacement in the owl monkey. Invest. Ophthalmol. Vis. Sci.,1976, 15 (ARVO suppl.), 76 (abstr.).Google Scholar
  54. (54).
    HULTSCH, E.–Vitreous structure and ocular inflammation In• Silverstein A.M., O’Connor G. R. (eds.), Immunology and immunopathology of the eye. Proceedings of the Second International Symposium, San Francisco, 1978. New York: Masson, 1979, 97–102.Google Scholar
  55. (55).
    PIETRASZ, B., HULTSCH, E. — Pathophysiology of vitreous hyaluronic acid Invest. Ophthalmol. Vis. Sci.,1980, 19 (ARVO suppl.), 232 (abstr.).Google Scholar
  56. (56).
    DARZYNKIEWICZ, Z., BALAZS, E. A. — Effect of connective tissue intercellular matrix on lymphocyte stimulation. I. Suppression of lymphocyte stimulation by hyaluronic acid. Exp. Cell Res., 1971, 66, 113–123.PubMedCrossRefGoogle Scholar
  57. (57).
    FORRESTER, J. V., WILKINSON, P.C. — Inhibition of leukocyte locomotion by hyaluronic acid. J. Cell Sci., 1981, 48, 315–331.PubMedGoogle Scholar
  58. (58).
    FORRESTER, J. V., BALAZS, E. A. — Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology, 1980, 40, 435–446.PubMedGoogle Scholar
  59. (59).
    BALAZS, E. A. — Discussion of: Intraocular injections as adjuncts to other retinal detachment procedures, by Shafer D.M. In: Schepens C.L., Regan C.D.J. (eds.), Controversial aspects of the management of retinal detachment, Boston: Little, Brown, 1965, 200–201.Google Scholar
  60. (60).
    BALAZS, E. A., SWEENEY, D. B. — The replacement of the vitreous -body in the monkey by reconstituted vitreous and by hyaluronic acid. Mod. Probl. Ophthalmol., 1966, 4, 230–232.Google Scholar
  61. (61).
    SWEENEY, D.B. — Discussion of: intraocular injections as adjuncts to other retinal detachment procedures, by Shafer D. M. In: Schepens C. L., Regan C.D. J. (eds.), Controversial aspects of the management of retinal detachment, Boston: Little, Brown, 1965, 201–202.Google Scholar
  62. (62).
    BALAZS, E.A., SWEENEY, D.B. — The injection of hyaluronic acid and reconstituted vitreous into the vitreous cavity. In: McPherson A. (ed.), New and controversial aspects of retinal detachment, New York: Hoeber Med. Div., Harper and Row, 1968, 371–376.Google Scholar
  63. (63).
    POMERANTZEFF, O., PANKRATOV, M.M., WANG, G.J., SCHEPENS, C.L. — An optimized zoom ophthalmoscope. Ophthalmology, 1984, 91, 197–203.PubMedGoogle Scholar
  64. (64).
    Pankratov, M.M., Pomerantzeff, O., Pflibsen, K.P. — A new tool for safe and accurate endophotocoagulation. In: Proceedings of the Second International Symposium of Ocular Microsurgery: Recent Events and Prospects,Rome, 1985 (in press).Google Scholar
  65. (65).
    MICHELS, R.G. — Vitrectomy techniques in retinal reattachment surgery. Ophthalmology, 1979, 86, 556–585.Google Scholar
  66. (66).
    REGNAULT, F. R.: Vitreous hemorrhage: an experimental study. I. A macroscopic and isotopic study of the evolution of whole blood and hemoglobin. Arch. Ophthalmol., 1970, 83, 458–474.PubMedCrossRefGoogle Scholar
  67. (67).
    SANDERS, D., PEYMAN, G.A., FISHMAN, G., VLCHEK, J., KOREY, M. — The toxicity of intravitreal whole blood and hemoglobin. Graefe’s Arch. Clin. Exp. Ophthalmol., 1975, 197, 255–267.CrossRefGoogle Scholar
  68. (68).
    THE RETINA SOCIETY TERMINOLOGY COMMITTEE. — The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology, 1983, 90, 12 1125.Google Scholar
  69. (69).
    HSU, H.T., DOREY, K, SORGENTE, N., RYAN, S. J. — Surgical removal of vitreous: its effect on intraocular fibroblast proliferation in the rabbit. Arch. Ophthalmol., 1984, 102, 605–607.Google Scholar
  70. (70).
    JARUS, G., BLUMENKRANZ, M., HERNANDEZ, E., SOSSI, N. — Clearance of intravitreal fluorouracil: normal and aphakic vitrectomized eyes. Ophthalmology, 1985, 92, 91–96.Google Scholar
  71. (71).
    CASE, J.L., PEYMAN, G.A., BARRADA, A., HENDRICKS, R., FISCELLA, R., HINDI, M. — Clearance of intravitreal 3H-fluorouracil. Ophthalmic Surg, 1985, 16, 378–381.PubMedGoogle Scholar
  72. (72).
    SANTANA, M., WIEDEMANN, P., KIRMANI, M., MINCKLER, D.S., PATTER-SON, R., SORGENTE, N., RYAN, S. J. — Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit. Graefe’s Arch. Clin. Exp. Ophthalmol., 1984, 221, 210–213.Google Scholar
  73. (73).
    RYAN, S. J. — Role of the vitreous in the hemoglobinopathies. Trans. Ophthalmol. Soc. UK, 1975, 95, 403–406.Google Scholar
  74. (74).
    FORSTER, R.K. — Etiology and diagnosis of bacterial postoperative endophthalmitis. (Symposium: Postoperative Endophthalmitis), Ophthalmology, 1978, 85, 320–326.PubMedGoogle Scholar
  75. (75).
    VERBRAEKEN, H., VAN LAETHEM, J. — Treatment of endophthalmitis with and without pars plana vitrectomy. Ophthalmologica, 1985, 191, 1–3.Google Scholar
  76. (76).
    CAMPBELL, D. G. — Erythroclast glaucoma following vitrectomy. In: Freeman, H.M., Hirose, T., Schepens C. L. (eds.), Vitreous surgery and advances in fundus diagnosis and treatment, New York: Appleton-Century-Crofts, 1977, 365–368.Google Scholar
  77. (77).
    PEYMAN, G.A., SANDERS, D.R., MINATOYA, M. — Pars plana vitrectomy in the management of pupillary block glaucoma following irrigation and aspiration. Br. J. Ophthalmol., 1978, 62, 336–339.PubMedCrossRefGoogle Scholar
  78. (78).
    SIMMONS, R.J. — Malignant glaucoma. Br. J. Ophthalmol., 1972, 56, 263–272.PubMedCrossRefGoogle Scholar
  79. (79).
    SIMMONS, R.J. — Malignant glaucoma. In: Heilmann F., Richardson K.T. (eds.), Glaucoma: conceptions of a disease; pathogenesis, diagnosis, therapy. Philadelphia: W.B. Saunders, 1978, 343–347.Google Scholar
  80. (80).
    MICHELS, R.G., KNOX, D. L., EROZAN, Y. S., GREEN, W.R. — Intraocular reticulum cell sarcoma: diagnosis by pars plana vitrectomy. Arch. Ophthalmol., 1975, 93, 1331–1335.PubMedCrossRefGoogle Scholar
  81. (81).
    HUTTON, W. L., VAISER, A., SNYDER, W. B. — Pars plana vitrectomy for removal of intravitreous cysticercus. Am. J. Ophthalmol., 1976, 81, 571–573.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • C. L. Schepens

There are no affiliations available

Personalised recommendations